← The Wire
EXOZNasdaq
EXOZYMES INC.
Biological Products, (No Diagnostic Substances) · NV · CIK 2010788
EXOZYMES INC. develops AI-designed enzymes for sustainable, scalable cell-free biomanufacturing of valuable chemicals
$65M
Market cap
$8.42
Last close
+4.9%
1D
+2.9%
5D
20K
Volume
Price · last 39 sessions-15.1%
May 4L $6.33 · H $10.54Jun 29
46
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 26, 20268-KMaterial Agreement · Reg FD DisclosureJun 17, 20268-KMaterial Agreement · Reg FD DisclosureJun 8, 2026424B5424B5Jun 8, 2026424B5424B5Jun 4, 2026424B5424B5May 29, 202610-Q10-QMay 14, 20268-KCompany UpdateMay 7, 20268-KCompany UpdateApr 10, 2026424B5424B5Apr 9, 20268-KCompany UpdateMar 31, 202610-K10-KMar 30, 20268-KCompany UpdateFeb 5, 20268-KCompany UpdateDec 12, 20258-KCompany UpdateNov 13, 202510-Q10-QNov 13, 20258-KCompany UpdateOct 3, 202510-Q10-QAug 12, 20258-KShareholder VoteJul 28, 20258-KCompany UpdateJul 8, 20258-KMaterial AgreementJun 26, 2025DEF 14ADEF 14AJun 20, 20258-KExecutive ChangeJun 20, 202510-Q10-QMay 12, 20258-KCompany UpdateApr 2, 20258-KCompany UpdateApr 2, 202510-K10-KMar 31, 20258-KExecutive ChangeFeb 21, 20258-KBylaw AmendmentFeb 11, 2025SC 13DSC 13DNov 18, 2024SC 13DSC 13DNov 18, 2024SC 13DSC 13DNov 18, 2024SC 13DSC 13DNov 18, 20248-KMaterial Agreement · Company UpdateNov 18, 202410-Q10-QNov 12, 2024424B4424B4Nov 12, 2024424B4424B4Nov 12, 2024S-1/AS-1/AOct 21, 2024S-1/AS-1/AOct 4, 2024S-1/AS-1/ASep 19, 2024S-1/AS-1/ASep 6, 2024S-1/AS-1/AAug 1, 2024S-1/AS-1/AMay 22, 2024S-1/AS-1/AApr 17, 2024S-1/AS-1/AFeb 14, 2024S-1S-1Feb 9, 2024
Similar companies
Comparable business profile · signals at a glance